ELAN logo
ELAN NYSE US

Elanco Animal Health Incorporated Common Stock

Healthcare · Pharmaceuticals Website · IPO Sep 2018
$23.24
▲ +$0.01 (+0.04%)
Vol 109K
Mkt Cap
$11.5B
ROE
-3.5%
Margin
-4.9%
Beta
1.88
52W
$8–$28

Wall Street Consensus

22 analysts · Apr 2026
8
Strong Buy
12
Buy
2
Hold
0
Sell
0
Strong Sell
90.9%
Buy Rating

Price Chart

Earnings

Beat rate: 100.0%
Next Report May 13, 2026
EPS Estimate: $0.35
Quarter EPS Est EPS Act Surprise
Mar 2026 $0.35
Dec 2025 $0.11 $0.13 +$0.02
Sep 2025 $0.13 $0.19 +$0.06
Jun 2025 $0.20 $0.26 +$0.06

Quarterly Revenue & Earnings

Quarter 2024-0… 2024-1… 2025-0… 2025-0… 2025-0… 2025-1…
Revenue $1.0B $1.2B $1.2B $1.1B $1.1B
Net Income -$8.0M $67.0M $11.0M -$34.0M -$276.0M

Key Ratios

ROA (TTM)
-1.7%
P/S (TTM)
2.44
P/B
1.7
EPS (TTM)
$-0.48
CF/Share
$-0.92
Rev Growth 3Y
+2.3%
52W High
$27.72
52W Low
$8.02
$8.02 52-Week Range $27.72

Financial Health

Free Cash Flow
$46.0M
Net Debt
$3.5B
Cash
$545.0M
Total Debt
$4.0B
As of Dec 31, 2025

How does ELAN compare to Pharmaceuticals peers?

Peer group: Peers · Pharmaceuticals (Peers) · 10 companies

ELAN valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (19.7)
vs Peers
vs Industry
Overvalued
P/S ratio
2.4
50% below peers (4.9)
vs Peers
vs Industry
Undervalued
P/B ratio
1.7
69% below peers (5.5)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (2.5%)
vs Peers
vs Industry
Strong yield

ELAN profitability vs Pharmaceuticals peers

ROE
-3.5%
115% below peers (22.7%)
vs Peers
vs Industry
Weak
Net margin
-4.9%
123% below peers (21.4%)
vs Peers
vs Industry
Weak
Gross margin
55.0%
24% below peers (72.6%)
vs Peers
vs Industry
Weak
ROA
-1.7%
130% below peers (5.9%)
vs Peers
vs Industry
Weak

ELAN financial health vs Pharmaceuticals peers

D/E ratio
0% below peers (139.5)
vs Peers
vs Industry
In line
Current ratio
2.2
40% above peers (1.6)
vs Peers
vs Industry
Strong liquidity
Beta
1.9
346% above peers (0.4)
vs Peers
vs Industry
More volatile

ELAN fundamentals radar

ELAN Peer median Industry

ELAN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ELAN vs peers: key metrics

Insider Activity

Neutral
Buys
12
Sells
0
DE BRABANDER ELLEN
Officer · Apr 01
award
40985 shs
SIMMONS JEFFREY N.
Chief Executive Officer · Feb 27
award
516360 shs
VANHIMBERGEN ROBERT M
Chief Financial Officer · Feb 27
award
23675 shs
CABRAL RAMIRO MARTIN
Officer · Feb 27
award
80887 shs
KINARD DAVID S
Officer · Feb 27
award
42557 shs
MEER JAMES M
Officer · Feb 27
award
14805 shs
BETTINGTON TIMOTHY J
Officer · Feb 27
award
55792 shs
CORREIA DE SIMAS JOSE MANUEL
Officer · Feb 27
award
32871 shs
DE BRABANDER ELLEN
Officer · Feb 27
award
92924 shs
MODI RAJEEV A
Officer · Feb 27
award
55895 shs
Last 90 days

Insider Buy Returns

KURZIUS LAWRENCE ERIK
Dec 12, 2025
$213000 +9.11%
SIMMONS JEFFREY N.
Dec 11, 2025
$478496 +6.85%
VANHIMBERGEN ROBERT M
Dec 11, 2025
$150426 +7.39%
MODI RAJEEV A
Dec 11, 2025
$95985 +8.95%

Top Holders

Top 5: 54.7%
Dodge & Cox Inc.
15.91%
$1.8B
FMR, LLC
10.50%
$1.2B
Vanguard Group Inc
9.67%
$1.1B
Blackrock Inc.
9.32%
$1.1B
Primecap Management Company
9.30%
$1.1B
As of Dec 31, 2025